Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and provider of regulatory services for rapid diagnostic tests and med-tech, announces the official opening yesterday of its
Abingdon Health plc Launch of LVOne Stroke Test by UpFront Diagnostics
UK Launch of LVOne Stroke Triage Test by UpFront Diagnostics
Abingdon Health updates on collaboration with 4TEEN4 Pharmaceuticals
Abingdon Health plc (AIM: ABDX) has provided an update on its partnership with 4TEEN4 Pharmaceuticals GmbH, focused on the co-development of a companion diagnostic for a potentially life-saving shock therapy.
Abingdon Health plc (AIM: ABDX) $2.5m Contract for clinical self-test development
$2.5m Contract Award for development of clinical self-test
US freezes UK trade talks after Starmer ‘lets America down’ over Chagos
The US has signalled that trade talks with Britain are on hold, after Keir Starmer was accused of “letting down” Washington over plans to transfer the Chagos Islands to Mauritius.
Abingdon Health plc (AIM: ABDX) c.US$2m multiplex diagnostic test contract win
c.US$2m multiplex diagnostic test contract win Development, scale-up and technical transfer for a semi-quantitative, multiplex lateral flow test system
ITV shares surge 18% on talks to sell broadcasting arm to Sky
ITV plc shares soared 18% in early London trading after the broadcaster confirmed discussions with Sky regarding the potential sale of its broadcasting operations.
FTSE Holds Steady as Investors Await Interest Rate Direction
London stocks ended mixed on Thursday as investors digested a varied slate of corporate updates and remained cautious ahead of next week’s UK inflation figures, which could shape the Bank
UK Stocks Slip as Minister Admits Economy Is in ‘Stagnation’
UK stocks fell on Thursday after Labour minister Stephen Kinnock conceded that the British economy is in a state of “stagnation”, following disappointing growth figures.
Abingdon Health plc (AIM: ABDX) Trading update
Revenue for FY25 in line with market expectations of £8.6m Continued strong revenue growth anticipated in FY26
Abingdon Health plc (AIM: ABDX) c. US$2.5m companion diagnostic test contract win
c. US$2.5m companion diagnostic test contract win Full CDMO service contract for development, scale-up, technical transfer, manufacture and full regulatory support
British Travellers to Face €20 EU Entry Fee from 2026
British travellers heading to the EU will likely have to pay a €20 visa-waiver fee from late 2026, nearly tripling the original €7 charge.